IVZ vs PMCB · rev $3.57B vs $8.6M cap
Invesco Plc (IVZ) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
Latest reported PMCB revenue for 2026-04-30 was $0. Net income was -$19.4M. PMCB currently screens at market cap $8.6M.
IVZ currently screens at market cap $12.76B. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the IVZ and PMCB stock pages for the full models.
Not investment advice.